Potential roles of gut microbiota and microbial metabolites in Parkinson's disease

被引:65
作者
Zheng, Shen-Yuan [1 ,2 ]
Li, Hai-Xia [1 ,2 ]
Xu, Rui-Chen [1 ,2 ]
Miao, Wen-Teng [1 ,3 ]
Dai, Ming-Yuan [1 ,4 ]
Ding, Song-Tao [1 ]
Liu, Han-Deng [1 ,5 ]
机构
[1] Chongqing Med Univ, Expt Teaching Ctr, Lab Tissue & Cell Biol, Chongqing, Peoples R China
[2] Chongqing Med Univ, Coll First Clin, Chongqing, Peoples R China
[3] Chongqing Med Univ, Coll Pediat, Chongqing, Peoples R China
[4] Chongqing Med Univ, Coll Clin 2, Chongqing, Peoples R China
[5] Chongqing Med Univ, Dept Cell Biol & Genet, Mol Med & Canc Res Ctr, Chongqing 400016, Peoples R China
关键词
Parkinson's disease; Gut microbiota; Microbial metabolites; Gut-brain axis; Short-chain fatty acids; Microbiota-targeted therapies; CHAIN FATTY-ACIDS; ALPHA-SYNUCLEIN; BRAIN AXIS; HYDROGEN-SULFIDE; SODIUM-BUTYRATE; INTESTINAL MICROBIOTA; DOPAMINERGIC-NEURONS; NONMOTOR SYMPTOMS; MOTOR FUNCTIONS; DOUBLE-BLIND;
D O I
10.1016/j.arr.2021.101347
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Parkinson's disease (PD) is a complicated neurodegenerative disease attributed to multifactorial changes. However, its pathological mechanism remains undetermined. Accumulating evidence has revealed the emerging functions of gut microbiota and microbial metabolites, which can affect both the enteric nervous system and the central nervous system via the microbiota-gut-brain axis. Accordingly, intestinal dysbiosis might be closely associated with PD. This review explores alterations to gut microbiota, correlations with clinical manifestations of PD, and briefly probes the underlying mechanisms. Next, the highly controversial roles of microbial metabolites including short-chain fatty acids (SCFAs), H2 and H2S are discussed. Finally, the pros and cons of the current treatments for PD, including those targeting microbiota, are assessed. Advancements in research techniques, further studies on levels of specific strains and longitudinal prospective clinical trials are urgently needed for the identification of early diagnostic markers and the development of novel therapeutic approaches for PD.
引用
收藏
页数:16
相关论文
共 50 条
[11]   Parkinson's Disease and Gut Microbiota [J].
Hirayama, Masaaki ;
Ohno, Kinji .
ANNALS OF NUTRITION AND METABOLISM, 2021, 77 :28-35
[12]   Altered gut microbiota and intestinal permeability in Parkinson's disease: Pathological highlight to management [J].
Sharma, Shakshi ;
Awasthi, Anupam ;
Singh, Shamsher .
NEUROSCIENCE LETTERS, 2019, 712
[13]   Diagnostic potential of gut microbiota in Parkinson's disease [J].
Petrov, V. A. ;
Alifirova, V. M. ;
Saltykova, I., V ;
Zhukova, I. A. ;
Zhukova, N. G. ;
Dorofeeva, Yu B. ;
Ikkert, O. P. ;
Titova, M. A. ;
Mironova, Yu S. ;
Sazonov, A. E. ;
Karpova, M. R. .
BYULLETEN SIBIRSKOY MEDITSINY, 2019, 18 (04) :92-101
[14]   Roles of Gut Microbial Metabolites in Diabetic Kidney Disease [J].
Fang, Qing ;
Liu, Na ;
Zheng, Binjie ;
Guo, Fei ;
Zeng, Xiangchang ;
Huang, Xinyi ;
Ouyang, Dongsheng .
FRONTIERS IN ENDOCRINOLOGY, 2021, 12
[15]   Gut microbiota and inflammation in Parkinson's disease: Pathogenetic and therapeutic insights [J].
Guo, Tong ;
Chen, Li .
EUROPEAN JOURNAL OF INFLAMMATION, 2022, 20
[16]   Gut, oral and nasal microbiota and Parkinson's disease [J].
Shen, Liang .
MICROBIAL CELL FACTORIES, 2020, 19 (01)
[17]   Alteration of Gut Microbial Metabolites in the Systemic Circulation of Patients with Parkinson's Disease [J].
Chen, Szu-Ju ;
Chen, Chieh-Chang ;
Liao, Hsin-Yu ;
Wu, Yu-Wei ;
Liou, Jyh-Ming ;
Wu, Ming-Shiang ;
Kuo, Ching-Hua ;
Lin, Chin-Hsien .
JOURNAL OF PARKINSONS DISEASE, 2022, 12 (04) :1219-1230
[18]   The gut microbiome in Parkinson's disease: A culprit or a bystander? [J].
Keshavarzian, Ali ;
Engen, Phillip ;
Bonvegna, Salvatore ;
Cilia, Roberto .
RECENT ADVANCES IN PARKINSON'S DISEASE, 2020, 252 :357-450
[19]   Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson's disease by regulating gut microbiota [J].
Zhang, Yi ;
Xu, Shaoqing ;
Qian, Yiwei ;
Mo, Chengjun ;
Ai, Penghui ;
Yang, Xiaodong ;
Xiao, Qin .
FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
[20]   Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease [J].
Kaur, Gagandeep ;
Behl, Tapan ;
Bungau, Simona ;
Kumar, Arun ;
Uddin, Md Sahab ;
Mehta, Vineet ;
Zengin, Gokhan ;
Mathew, Bijo ;
Shah, Muhammad Ajmal ;
Arora, Sandeep .
CURRENT NEUROPHARMACOLOGY, 2021, 19 (02) :233-247